Clinical TrialsSearch results
Number of results: 691
Recruiting
- A PHASE 1/2 STUDY OF ORAL LOXO-292 IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING RET-FUSION NON-SMALL CELL LUNG CANCER, MEDULLARY THYROID CANCER, AND OTHER TUMORS WITH INCREASED RET ACTIVITY
- Advanced Solid Tumors, Including RET-Fusion Non Small Cell Lung Cancer, Medullary Thyroid Cancer, an
- Hokonohara Toshihiro
- 2022-07-02
Other
- Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study
- Advanced stage lymphoblastic lymphoma of children.
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Recruiting
- The safety and efficacy of oral cancer vaccine B440
- Advanced urothelial carcinoma
- Teishima Jun
- 2022-12-27
Other
- Phase II study of a combination of CPT-11, 5FU/l-LV and UFT/LV in patients with advanced/recurrent colorectal cancer
- advanced/recurrent colorectal cancer
- Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
- 2007-03-01
Other
- A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)
- advanced/recurrent gastric cancer
- OGSG
- 2009-07-10
Other
- The effect of synbiotics on airway
- After tracheotomy, after laryngotracheal separation
- Bitoh Yuko
- 2020-07-30
Recruiting
- surgical trauma and postoperative complications
- All diseases for which surgery is performed
- Hirose Munetaka
- 2023-10-18
Other
- Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
- All patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).
- West Japan Oncology Group
- 2005-08-22
Recruiting
- A study of treatment of allergic disorders with MSC-CM
- Allergic Disorder (such as Pollinosis or Atopic Dermatitis)
- Nagamine Yukiko
- 2024-01-26
Recruiting
- A study of treatment of Alopecia with MSC-CM
- Alopecia
- Hirayama Takashi
- 2024-05-07